Intco Medical Technology Co., Ltd. announced that it has received CNY 499.999981 million in funding
January 03, 2021
Share
On January 4, 2021, Intco Medical Technology Co., Ltd. closed the transaction. The company obtained the confirmation of the acceptance of share registration application issued by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. After the issuance, Liu Fangyi owns 141,068,874 shares in the company, accounting for 40.10% stake. Prior to the issuance, Liu Fangyi held 82,435,560 shares in the company, accounting for 37.08% stake. The company paid issue fees of CNY 4,167,373.12 including CNY 2,830,188.68 for sponsorship and underwriting fee, CNY 566,037.73 for audit and verification fee, CNY 754,716.96 for legal fees, and CNY 16,429.75 for issuance registration fee and other fees and received net proceeds of CNY 495,832,608.02.
Intco Medical Technology Co Ltd, formerly SHANDONG INTCO MEDICAL PRODUCTS CO., LTD., is a China-based company principally engaged in the research and development, manufacture and sales of medical care products. The Company's main products include medical care products, rehabilitation care products, health care products and inspection supplies, such as disposable gloves, wheelchairs, hot and cold compresses and electrode sheets. Its products are mainly used in medical institutions, pension care institutions, household commodity and other related industries. The Company distributes its products in domestic market and to overseas markets.